Lakefront Biotherapeutics NV
LKFT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001421876
No open-market purchases or sales by Lakefront Biotherapeutics NV insiders were filed in the last 90 days; 76 institutions reported holding it in 13F filings for Q2 2026, worth $960.3M in total; Greenlight Capital is the only superinvestor holding it.
Other share classesGLPGF
Holders of 5% or more of LKFT
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Lakefront Biotherapeutics NV, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Gilead Sciences, Inc. | 13D/A | 29.90%21.0M shares | – | Jan 10, 20251 filing | Jan 10, 2025 | SEC |
| EcoR1 Capital, LLC | 13D/A | 13.22%8.71M shares | +1.38 ppfrom 11.84% | May 19, 20252 filings | Jul 28, 2025 | SEC |
| Tang Capital Management LLC | 13G | 8.40%5.56M shares | +0.90 ppfrom 7.50% | Feb 14, 20252 filings | Oct 29, 2025 | SEC |
| Madison Avenue Partners, LP | 13G | 5.50%3.61M shares | New | Jun 23, 20261 filing | Jun 23, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on Lakefront Biotherapeutics NV, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jun 23, 20266:49 PM ET | Madison Avenue Partners, LPand 5 others | 13G | 5.50%3.61M shares | New | Jun 15, 2026 | SEC |
| Oct 29, 20256:30 PM ET | Tang Capital Management LLCand 5 others | 13G | 8.40%5.56M shares | +0.90 ppfrom 7.50% | Oct 27, 2025 | SEC |
| Jul 28, 20258:37 PM ET | EcoR1 Capital, LLCand 3 others | 13D/A | 13.22%8.71M shares | +1.38 ppfrom 11.84% | Jul 24, 2025 | SEC |
| May 19, 20256:33 PM ET | EcoR1 Capital, LLCand 3 others | 13D/A | 11.84%7.80M shares | – | May 15, 2025 | SEC |
| Feb 14, 20258:00 PM ET | Tang Capital Management LLCand 6 others | 13D | 7.50%4.91M shares | New | Feb 7, 2025 | SEC |
| Jan 10, 20253:46 PM ET | Gilead Sciences, Inc.and 1 other | 13D/A | 29.90%21.0M shares | – | Jan 7, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Lakefront Biotherapeutics NV shares.
No Form 144 notices for Lakefront Biotherapeutics NV are on file.